Glenmark Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : GLENMARK
NIFTY : NIFTY Midcap 100
NIFTY SECTOR : Nifty Pharma

About Company

Glenmark Pharmaceuticals Limited is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Specialty Business: Drug Discovery: Glenmark’s ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. Specialty Business: Formulations Business: Glenmark’s formulations business is currently organized many regions - India, Latin America, Central Eastern Europe and Semi Regulated Markets of Africa/Asia/CIS. The formulations business focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology.

Market Cap. ₹ 40,719 Cr.

52 Week - High/Low ₹ 1,831/985

P/E Ratio 6.42

P/B Ratio 1.70

Enterprise Value ₹ 42,148 Cr.

ROE % 25.3

RSI Value 55.15

EMA 50 1422.37

EMA 200 1422.9

Market Cap. ₹ 40,719 Cr.

52 Week - High/Low ₹ 1,831/985

P/E Ratio

P/B Ratio 4.97

Enterprise Value ₹ 36,973 Cr.

ROE % -21.18

RSI Value 55.15

EMA 50 1422.37

EMA 200 1422.9

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us